Moreover, increases in the circulating BMP2 was reported here at early and late stage of diabetes, 6 week–12 months from onset of the experimental diabetes leading us to hypothesize that the circulating level of BMP2 could be a biomarker in the diabetic patients. This evidence concerns the gene BMP2 and diabetes mellitus.